Correlation Between C Rad and Xvivo Perfusion
Can any of the company-specific risk be diversified away by investing in both C Rad and Xvivo Perfusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C Rad and Xvivo Perfusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C Rad AB and Xvivo Perfusion AB, you can compare the effects of market volatilities on C Rad and Xvivo Perfusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C Rad with a short position of Xvivo Perfusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of C Rad and Xvivo Perfusion.
Diversification Opportunities for C Rad and Xvivo Perfusion
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between CRAD-B and Xvivo is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding C Rad AB and Xvivo Perfusion AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xvivo Perfusion AB and C Rad is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C Rad AB are associated (or correlated) with Xvivo Perfusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xvivo Perfusion AB has no effect on the direction of C Rad i.e., C Rad and Xvivo Perfusion go up and down completely randomly.
Pair Corralation between C Rad and Xvivo Perfusion
Assuming the 90 days trading horizon C Rad is expected to generate 2.72 times less return on investment than Xvivo Perfusion. In addition to that, C Rad is 1.14 times more volatile than Xvivo Perfusion AB. It trades about 0.06 of its total potential returns per unit of risk. Xvivo Perfusion AB is currently generating about 0.18 per unit of volatility. If you would invest 45,000 in Xvivo Perfusion AB on September 1, 2024 and sell it today you would earn a total of 3,000 from holding Xvivo Perfusion AB or generate 6.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 95.65% |
| Values | Daily Returns |
C Rad AB vs. Xvivo Perfusion AB
Performance |
| Timeline |
| C Rad AB |
| Xvivo Perfusion AB |
C Rad and Xvivo Perfusion Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C Rad and Xvivo Perfusion
The main advantage of trading using opposite C Rad and Xvivo Perfusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C Rad position performs unexpectedly, Xvivo Perfusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xvivo Perfusion will offset losses from the drop in Xvivo Perfusion's long position.| C Rad vs. CellaVision AB | C Rad vs. Biotage AB | C Rad vs. Boule Diagnostics AB | C Rad vs. RaySearch Laboratories AB |
| Xvivo Perfusion vs. Vitrolife AB | Xvivo Perfusion vs. BioArctic AB | Xvivo Perfusion vs. CellaVision AB | Xvivo Perfusion vs. Invisio Communications AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |